about
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, ...
Read More
29.54
-0.38
(-1.27%)
216.2K
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Galecto Inc is on 12 Aug 2026 for the purpose of Damora Therapeutics Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Galecto Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..